Neoadjuvant Nivolumab for Operable Esophageal Carcinoma

Clinical trial NCT03987815 · UNKNOWN

Trial details

NCT number: NCT03987815
Sponsor: Samsung Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Squamous Cell Carcinoma

Start date: 2019-08-01
Primary completion: 2021-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.